Answers are grounded in this paper and cite their sources.
The purpose of this viewpoint is to provide awareness of the current opportunities to enhance a high-value care approach to blood product transfusion. It provides a historical context to the evolution of blood management, as well as of the patient safety and high-value care movement. Leveraging current technology for enhanced education, as well as clinical decision support, is also discussed.
No takes yet. Share an insight, caveat, or question.
Moisés Aurón (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: